姜黄素
医学
胃肠病学
内科学
肝纤维化
非酒精性脂肪肝
纤维化
脂肪肝
安慰剂
肝活检
活检
病理
疾病
药理学
替代医学
作者
Saeede Saadati,Azita Hekmatdoost,Behzad Hatami,Asieh Mansour,Zahra Zahra,Mehdi Hedayati,Amir Sadeghi
摘要
AIM: The aim of this study was to examine the effects of curcumin supplementation on hepatic fibrosis using different fibrosis assessment methods. BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) may progress to hepatic fibrosis. Detection of hepatic fibrosis should be measured by liver biopsy, which is an invasive method. Thus, some non-invasive methods are suggested. METHODS: Hepatic fibrosis was evaluated in forty six patients with NAFLD before and three months after supplementation with 1.5 gram curcumin or placebo. Methods of assessments included fibroscan, and calculating non-invasive marker panel including FIB-4 (Fibrosis4), NFS (NAFLD fibrosis score), APRI (AST (Aspartate aminotransferase) Platelet Ratio Index), and BARD (body mass index, AST/ALT (Alanine aminotransferase ratio, diabetes). RESULTS: Fibrosis score was reduced significantly after curcumin supplementation using fibroscan (p<0.01), FIB-4 (p<0.05) and APRI (p<0.05) tests, while fibrosis score did not change significantly using BARD and NFS methods (p>0.05). CONCLUSION: Our results revealed that fibroscan, FIB-4, and APRI are similar in assessment of hepatic fibrosis changes after curcumin supplementation. Future studies with higher sample sizes are needed to confirm these results.
科研通智能强力驱动
Strongly Powered by AbleSci AI